Growth Metrics

Thermo Fisher Scientific (TMO) Cash from Operations (2016 - 2025)

Thermo Fisher Scientific (TMO) has disclosed Cash from Operations for 16 consecutive years, with 3290000000.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Cash from Operations fell 11.63% year-over-year to 3290000000.0, compared with a TTM value of 8667000000.0 through Dec 2024, up 3.1%, and an annual FY2025 reading of 7818000000.0, down 9.8% over the prior year.
  • Cash from Operations was 3290000000.0 for Q4 2024 at Thermo Fisher Scientific, up from 2166000000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 3723000000.0 in Q4 2023 and bottomed at 356000000.0 in Q1 2020.
  • Average Cash from Operations over 5 years is 2191400000.0, with a median of 2184000000.0 recorded in 2022.
  • The sharpest move saw Cash from Operations soared 455.62% in 2021, then tumbled 66.89% in 2023.
  • Year by year, Cash from Operations stood at 3339000000.0 in 2020, then decreased by 26.42% to 2457000000.0 in 2021, then surged by 41.92% to 3487000000.0 in 2022, then grew by 6.77% to 3723000000.0 in 2023, then dropped by 11.63% to 3290000000.0 in 2024.
  • Business Quant data shows Cash from Operations for TMO at 3290000000.0 in Q4 2024, 2166000000.0 in Q3 2024, and 1960000000.0 in Q2 2024.